Safety and Efficacy of AVP-923 in the Treatment of Levodopa-induced Dyskinesia in Parkinson's Disease Patients
Clinical trial NCT01767129 · COMPLETED
Trial details
- NCT number
- NCT01767129
- Sponsor
- Avanir Pharmaceuticals
- Status
- COMPLETED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2013-10-16
- Primary completion
- 2015-02-05
- Enrollment
- 14
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.